• Scientific Publications and Presentations - Urology

    Publications

    Journal Articles

    1. Rieger-Christ KM, Hanley RS, Lodowsky C, Bernier T, Vemulapalli P, Roth M, Kim J, Yee AS, S. Le Meé, P.J. Marie, Libertino JA and Summerhayes IC. The Green Tea Compound, (-) - Epigallocatechin-3-gallate Down-Regulates N-Cadherin and Suppresses Migration of Bladder Carcinoma Cells. J. Cell. Biochem. 2007;102(2):377-388.

       
    2. Jacobs MA, Wotkowicz C, Baumgart ED, Silva Neto B, Rieger-Christ KM, Bernier T, Cohen MS, Libertino JA, Summerhayes IC. Epidermal Growth Factor Receptor Status and the Response of Bladder Carcinoma Cells to Erlotinib. J. Urol. 2007;178(4): 1510-1514.

       
    3. Baumgart E, Cohen MS, Silva Neto B, Jacobs M, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA and Summerhayes IC. Identification and prognostic significance of an epithelial to mesenchymal expression profile in human bladder tumors. Clin. Cancer Res. 2007;13(6):1685-1694.

       
    4. Cohen MS, Triaca V, Billmeyer B, Hanley RSS, Girshovich L, Shuster T, Oberfield RA, Zinman L. Coordinated Chemoradiation Therapy with Genital Preservation in the Treatment of Primary Invasive Carcinoma of the Male Urethra. The Journal of Urology. Vol. 179; February 2008.

       
    5. Silva Neto B, Smith GL, Mandeville JA, Vanni AJ, Wotkowicz C, Rieger-Christ KM, Baumgart E, Jacobs MA, Cohen MS, Zeheb R, Loda M, Libertino JA and Summerhayes IC. Prognostic Significance of Altered p120ctn Expression in Bladder Cancer. Br. J. Urol. Int. (in press 2008)

    Chapters

    1. Zinman L. Contemporary Management of Rectourethral Fistulas. Reconstructive Urologic Surgery. Cleveland Clinic; 2008.
       
    2. Zinman L. Combined use of fasciocutaneous, muscular and myocutaneous flaps and graft onlays in urethral reconstruction. Reconstructive Urologic Surgery. Cleveland Clinic; 2008.


    Presentations 

    American Urological Association (AUA) Annual Meeting 2008 

    1. Fitch S, Cohen MS, Ruthazer R, Libertino JA. The Quest to Find High Grade Prostate Cancer: Are We Failing?

       
    2. Neto BS, Rieger-Christ KM, Neely LA, Eroshkin A, Garver J, Patel S, Phung NA, McLaughlin S, Whitney D, Libertino JA, Summerhayes, IC. MicroRNA Expression in Bladder Cancer: A Ratiometric Approach Identifies Invasive Potential.

       
    3. Kella N, Libertino JA, Tuerk IA, Moinzadeh A, Benson MC, Roser B, Amaya A, Topjian LM, Hruby GW, Landman J. Sutureless vesico-urethral anastomosis after radical prostatectomy: Initial clinical feasibility data from the Continuum study.

       
    4. Smith GL, Neto BS, Rieger-Christ KM, Mandeville JA, Vanni AJ, Libertino JA, Summerhayes IC. Prognostic Significance of Abnormal P-cadherin Expression in Transitional Cell Carcinoma of the Bladder.

       
    5. Mandeville JA, Smith GL, Vanni AJ, Rieger-Christ KM, Neto BS, Libertino JA, Summerhayes IC. P-cadherin is a Modulator of Migration Behavior in Bladder Carcinoma Cells.

       
    6. Smith GL, Cohen MS, Kurteva T, Libertino JA. Non-clamped, Non-ischemic Partial Nephrectomy in Patients with Compromised Preoperative Renal Function or with a Solitary Kidney.

       
    7. Stoffel JT, Smith GL, Mourtzinos AP, Bresette JF. Does Self-Reported Pad Use Following Pubovaginal Sling Surgery Accurately Reflect Patient Quality of Life?

       
    8. Kurteva T, Cohen MS, Smith GL, Libertino JA. Non-clamped, Non-ischemic Partial Nephrectomy: The New Gold Standard. 

    AUA Annual Meeting 2007

    1. Cohen MS, Hanley RSS, Ruthazer R, Libertino JA. A Meta-Analysis Evaluating the Accuracy of Prostate Gleason Biopsy in Over 11,000 Patients.

       
    2. Cohen MS, Libertino JA, Hanley RSS, Ruthazer R, Hamawy KJ, Roth RA, Sorcini A, Tuerk IA. Caution: Biopsy Gleason Score Inaccurately Predicts the Prostatectomy Gleason Score in Almost 50% of Patients.

       
    3. Smith GL, Zagha R, Libertino JA. Description of Technique and Initial Results: The Habib 4x Bipolar Resection Device in Open Nephron Sparing Surgery without Renal Artery Occlusion.

       
    4. Martiniez-Salamanca; Aragono; Bianco; Canes D; Carballido; Ciancio; Hernandez; Herranz; Huang W; Lopez; Martinez; Ballesteros; Palou; Pontes; Romero; Rosales; Russo; Soloway; Terrone; Tewari; Vaughan; Villavicencio; Wotkowicz C, Libertino JA. Prognostic Significance of Venous Thrombus in Renal Cell Carcinoma: A Multi-institutional Study.

       
    5. Wotkowicz C, Baumgart E, Jacobs M, Cohen MS, Neto BS, Rieger Christ KM, Libertino JA. Altered Localization of P120 Catenin in Bladder Cancer is Prognostic for Node Involvement.

       
    6. Canes D, Stoffel JT, Murray JJ, Marcello PW, Zinman L. Complex Radiation Rectourethral Fistula Repair with Buccal Mucosal Patch Graft and Gracilis Muscle Interposition Flap.  

    New England Section, AUA - 2007

    1. Canes D, Aragona M, Neto BS, Vanni AJ, Tuerk IA. Robotic Assisted Radical Prostatectomy: Comparison of Extraperitoneal and Transperitoneal Approaches During a Single Surgeon's Learning Curve.

       
    2. Smith GL, Neto BS, Rieger-Christ KM, Mandeville JA, Vanni AJ, Libertino JA, Summerhayes IC. Prognostic Significance of Abnormal P-cadherin Expression in Transitional Cell Carcinoma of the Bladder.

       
    3. Mandeville JA, Smith GL, Vanni AJ, Rieger-Christ KM, Neto BS, Libertino JA, Summerhayes IC. P-cadherin Is a Modulator of Migration Behavior in Bladder Carcinoma Cells.

       
    4. Vanni AJ, Mourtzinos AP, Mandeville JA, Smith GL, Rieger-Christ KM, Libertino JA, Summerhayes IC. The Efficacy of a Novel Therapeutic Approach Targeting the Fibroblast Growth Factor Receptor in Bladder Carcinoma Cells using PD173074.

       
    5. Stoffel JT, Smith GL, Mourtzinos AP, Bresette JF. Does Self-Reported Pad Use Following Pubovaginal Sling Surgery Accurately Reflect Patient Quality of Life?

       
    6. Vanni AJ, Mandeville JA, Smith GL, Vogel JM, Wilkie J, Libertino JA, Madras PN. Preliminary Observations of a Novel Intravascular Hemostatic Tool for Partial Nephrectomy.

       
    7. Baumgart E, Callum M, Jacobs M, Wotkowicz C, Libertino JA. Intravesical Gemcitabine for Treatment of BCG Resistant High-Risk Transitional Cell Carcinoma.

       
    8. Cohen MS, Triaca V, Billmeyer B, Hanley R, Girshovich L, Shuster T, Oberfield RA, Zinman L. Updated Outcomes with Coordinated Chemoradiation Therapy as the Primary Treatment for Invasive Carcinoma of the Male Urethra. 
       

     

     

  • Make An Appointment

    (781) 744-8762
  • "Clampless" Surgery a Success

    John A. Libertino, MD, chair, Institute of Urology, and director, Sophia Gordon Cancer Center, recently presented the findings of nearly 20 years of retrospective clinical data demonstrating that long term kidney function is significantly improved in cancer patients when their kidney tumor is removed via a new “clampless” variation of the traditional surgical procedure known as a partial nephrectomy.